aberr
activ
recent
emerg
major
contributor
pathogenes
neurodegen
disord
alzheim
huntington
diseas
commerci
avail
assay
measur
activ
commonli
use
veid
peptid
substrat
howev
method
well
suit
specif
assess
activ
presenc
confound
proteas
activ
often
encount
cell
tissu
sampl
report
develop
method
overcom
limit
use
protein
substrat
lamin
highli
specif
cleavag
amino
acid
use
neoepitop
antibodi
cleav
lamin
develop
electrochemiluminescencebas
elisa
assay
suitabl
specif
detect
quantifi
activ
highli
apoptot
cell
extract
method
sensit
veidbas
assay
adapt
highcont
imag
platform
highthroughput
screen
method
use
screen
character
inhibitor
compound
intervent
decreas
intracellular
activ
applic
neurodegen
disord
proteas
caspas
famili
known
import
mediat
apoptosi
commonli
subdivid
base
role
apoptosi
inflamm
apoptot
initi
apoptot
execution
inflammatori
caspas
definit
howev
becom
somewhat
inaccur
increas
number
nonapoptot
role
initi
execution
caspas
identifi
mediat
cell
differenti
matur
signal
event
caspas
distinguish
base
inher
differ
caspas
substrat
prefer
defin
shape
electrostat
potenti
activ
site
cleft
use
posit
scan
peptid
librari
consensu
recognit
sequenc
propos
caspas
led
develop
peptid
substrat
well
inhibitor
typic
consist
amino
acid
ie
devd
follow
fluoresc
tag
afc
methylcoumarin
substrat
warhead
fmk
fluoromethylketon
coval
bind
enzym
inhibitor
reagent
use
investig
caspas
constitut
major
caspaselik
activ
sampl
may
assum
activ
highli
apoptot
extract
howev
kmkcat
ratio
differ
less
fold
mani
wide
use
peptid
substrat
reagent
particularli
use
investig
activ
caspas
present
lower
concentr
cell
cultur
tissu
sampl
particular
development
signal
process
involv
cell
death
intracellular
caspas
activ
like
tight
control
endogen
caspas
inhibitor
proteasom
result
low
level
activ
difficult
detect
peptid
substrat
biolog
proteas
substrat
addit
factor
outsid
amino
acid
recognit
site
influenc
select
effici
proteolyt
cleavag
caspas
shown
amino
acid
residu
directli
scissil
bond
import
determin
cleavag
sinc
charg
bulki
residu
well
toler
furthermor
domain
far
away
cleavag
site
mediat
interact
substrat
proteas
exosit
although
interact
yet
shown
proteas
caspas
famili
high
variabl
cleavag
site
motif
natur
caspas
substrat
argu
favour
presenc
exosit
known
substrat
show
particularli
high
variabl
recognit
sequenc
cleavag
site
ideltv
e
dq
x
found
substrat
presenilin
endd
huntingtin
ivld
dna
topoisomeras
pedd
alpha
drhd
periplakin
tvad
fak
vswd
tgev
vvpd
garner
much
attent
recent
sinc
shown
involv
development
prune
axon
suggest
similar
pathway
might
erron
activ
neurodegen
disord
alzheim
ad
huntington
diseas
hd
presenc
activ
cleavag
substrat
inde
hallmark
ad
hd
cerebr
ischemia
shown
number
differ
anim
model
patient
brain
tissu
assess
activ
cell
tissu
sampl
peptid
substrat
inhibitor
need
titrat
accur
yield
meaning
result
sinc
peptid
substrat
commonli
use
assess
activ
veid
cleav
caspas
well
proteasom
use
high
concentr
addit
even
low
concentr
veid
substrat
lead
inaccur
result
rel
amount
proteolyt
activ
sampl
significantli
higher
due
small
differ
kcatkm
recent
develop
method
use
biotinyl
caspas
inhibitor
zvad
significantli
specif
achiev
specif
immunoprecipit
subsequ
detect
activ
caspas
western
blot
requir
quantit
way
assess
activ
develop
novel
method
base
cleavag
lamin
show
method
sensit
specif
allow
detect
activ
complex
sampl
assay
quantit
measur
activ
use
investig
biolog
well
screen
intracellular
efficaci
assess
inhibitor
order
develop
activ
assay
specif
avail
method
reli
cleavag
veid
peptid
decid
investig
cleavag
known
substrat
use
measur
activ
substrat
would
ideal
specif
possibl
particular
cleav
proteas
activ
apoptosi
cut
detect
quantiti
protein
substrat
easi
purifi
thu
avail
larger
amount
exist
neoepitop
antibodi
allow
specif
detect
cleavag
fragment
would
advantag
nuclear
lamin
protein
among
first
substrat
character
knockdown
studi
strongli
suggest
cleavag
apoptosi
highli
depend
presenc
furthermor
purifi
lamin
well
varieti
neoepitop
antibodi
cleavag
fragment
readili
avail
high
stabil
cleavag
fragment
without
degrad
apoptot
process
describ
facilit
detect
veid
peptid
sequenc
commonli
use
substrat
inhibitor
deriv
lamin
cleavag
site
sinc
protein
context
known
chang
kinet
specif
proteolyt
event
decid
compar
cleavag
veid
peptid
fulllength
lamin
protein
lamin
protein
specif
substrat
veid
peptid
therefor
decid
investig
whether
lamin
specif
substrat
particular
interest
abil
execution
caspas
cleav
lamin
sinc
like
show
high
activ
apoptot
extract
accur
quantif
activ
interest
first
subject
acveidafc
substrat
digest
caspas
respect
amount
activ
enzym
use
reaction
normal
concentr
activ
site
sampl
determin
titrat
irrevers
inhibitor
zvadfmk
fig
expect
veid
peptid
substrat
although
best
process
still
show
signific
cleavag
fig
high
substrat
concentr
mm
lower
substrat
concentr
use
achiev
greater
specif
howev
differ
kcatkm
veid
less
fold
caspas
result
small
concentr
window
exploit
achiev
select
amount
activ
present
howev
window
lost
sampl
contain
higher
concentr
activ
shown
figur
fold
molar
excess
enough
lead
significantli
higher
signal
nonspecif
make
veidbas
assay
problemat
use
apoptot
sampl
cell
tissu
lysat
high
level
activ
lamin
hand
show
proteolyt
process
incub
recombin
activ
correspond
amount
caspas
concentr
mm
fig
therefor
focuss
lamin
substrat
develop
specif
activ
assay
confirm
select
lamin
cleavag
made
use
mous
embryon
fibroblast
mef
cell
gener
wildtyp
mice
cell
differ
express
fig
make
ideal
system
studi
specif
substrat
apoptosi
induc
addit
nm
staurosporin
cultur
medium
activ
monitor
time
assess
cleavag
endogen
lamin
via
western
blot
fig
acveidafc
peptid
substrat
fig
antibodi
use
detect
full
length
lamin
kda
crossreact
close
relat
lamin
c
protein
kda
ntermin
fragment
cleav
lamin
c
detect
size
kda
fig
furthermor
use
cell
line
express
express
fig
found
lamin
protein
still
process
induct
apoptosi
camptothecin
fig
confirm
requir
process
increas
veid
cleavag
time
observ
cell
line
fig
cell
signific
increas
baselin
observ
time
point
wherea
cell
show
lower
veid
process
initi
nonsignific
increas
first
h
treatment
howev
later
timepoint
cell
exhibit
similar
level
veid
cleavag
highli
signific
increas
nontreat
control
fig
suggest
proteas
make
larg
proport
veid
cleavag
activ
apoptot
extract
result
indic
lamin
protein
substrat
much
specif
cleavag
veid
peptid
develop
electrochemiluminescencebas
elisa
method
quantit
assess
cleav
lamin
order
accur
quantit
amount
cleav
lamin
gener
turn
elisabas
assay
format
use
mesoscaleh
platform
allow
fast
sensit
detect
minim
background
use
electrochemiluminesc
determin
whether
cleavag
lamin
sensit
cleavag
veid
peptid
substrat
detect
low
level
activ
incub
differ
concentr
enzym
parallel
either
acveidafc
purifi
lamin
protein
determin
amount
cleavag
min
measur
fluoresc
sampl
acveidafc
subject
sampl
elisa
use
lamin
neoepitop
antibodi
lamin
cleavag
comparison
result
show
assay
perform
least
equal
well
detect
activ
concentr
nm
lamin
cleavag
assay
show
linear
concentrationrespons
relationship
lowest
caspas
concentr
test
fig
signaltonois
ratio
elisa
assay
low
nm
wherea
signaltonois
drop
veidbas
assay
concentr
fig
use
peptid
inhibitor
veidcho
assay
furthermor
arriv
similar
ic
valu
laminbas
elisa
nm
veidbas
assay
nm
indic
elisa
method
suitabl
assess
inhibit
small
molecul
peptid
overal
method
show
slight
increas
sensit
commonli
use
veid
cleavag
method
abl
reliabl
detect
concentr
nm
next
want
assess
whether
lamin
cleavag
assay
show
higher
specif
veidbas
system
proteas
activ
induct
apoptosi
end
test
lysat
deriv
staurosporinestress
mef
newli
develop
elisa
found
linear
increas
signal
time
wt
sampl
wherea
signal
sampl
remain
stabl
background
level
similar
background
seen
untreat
fig
indic
amount
intracellularli
cleav
figur
lamin
protein
specif
substrat
veid
peptid
mm
veidafc
incub
differ
amount
caspas
h
fluoresc
gener
cleavag
monitor
time
initi
linear
portion
curv
use
calcul
reaction
veloc
veid
preferenti
cleav
also
crossreact
caspas
higher
concentr
error
bar
sem
n
independ
experi
b
mm
veidafc
incub
mm
differ
amount
h
reaction
veloc
calcul
even
low
concentr
veidafc
peptid
substrat
cleav
fold
higher
molar
concentr
result
higher
signal
veid
cleavag
error
bar
sem
n
independ
experi
statist
signific
assess
anova
posthoc
dunnett
comparison
c
pure
lamin
protein
incub
differ
amount
caspas
min
sampl
separ
sdspage
fragment
cleav
lamin
detect
western
blot
antibodi
fulllength
lamin
ntermin
fragment
ctermin
fragment
cleavag
observ
caspas
gener
lamin
fragment
dosedepend
manner
repres
imag
independ
experi
shown
endogen
lamin
protein
highli
specif
readout
quantif
activ
staurosporineinduc
apoptosi
kinet
measur
either
acveidafc
lamin
cleavag
fluoresc
newli
develop
elisa
allow
comparison
kinet
paramet
two
substrat
find
fulllength
lamin
protein
lower
km
cleavag
site
peptid
veid
tabl
although
kcat
valu
also
decreas
kcatkm
still
higher
lamin
tabl
indic
bind
lamin
tighter
might
mediat
domain
outsid
cleavag
site
bind
site
could
also
respons
observ
specif
fulllength
protein
substrat
km
kcat
valu
veid
furthermor
good
agreement
previous
report
data
postul
involv
neuron
degener
apoptosi
detect
activ
neuron
cultur
therefor
paramount
interest
previou
studi
frequent
use
tunel
assay
measur
apoptosi
look
veidas
activ
presenc
activ
fragment
western
blot
immunostain
assess
presenc
cleav
substrat
specif
method
assess
effect
drug
treatment
activ
develop
far
use
antibodi
activ
fragment
level
figur
veid
lamin
ac
cleav
absenc
protein
fulllength
kda
detect
mef
gener
mice
b
endogen
lamin
protein
kda
cleav
wt
mef
staurosporin
stress
h
longer
antibodi
crossreact
fulllength
lamin
c
kda
cleav
band
kda
size
lamin
ac
lower
panel
c
cell
express
protein
wherea
mef
contain
caspas
hu
human
mous
ns
nonspecif
band
cell
stress
mm
camptothecin
differ
amount
time
cleavag
endogen
lamin
c
protein
monitor
western
blot
antibodi
antibodi
fulllength
lamin
ac
ctermin
fragment
e
schemat
represent
lamin
c
cleavag
site
aa
ntermin
fragment
gener
cleavag
red
size
kda
lamin
ac
f
mef
stress
nm
staurosporin
differ
amount
time
lysat
gener
analyz
cleavag
veidafc
cell
show
signific
increas
fluoresc
timepoint
fluoresc
signal
obtain
lysat
reach
statist
signific
differ
baselin
h
would
necessarili
chang
upon
inhibitor
treatment
immunoprecipit
activ
caspas
biotinyl
zvadfmk
depend
effici
precipit
western
blot
quantif
newli
develop
elisa
method
howev
could
directli
appli
neuron
cultur
sinc
lamin
express
embryon
mous
brain
neuron
earli
stage
develop
postnat
day
express
lamin
subtyp
differ
lamin
c
sequenc
caspas
cleavag
site
vevd
btype
lamin
veid
lamin
c
fig
furthermor
cleavag
lamin
site
specif
shown
cell
line
agreement
find
observ
cleavag
lamin
primari
cortic
neuron
deriv
mice
embryon
day
fig
lamin
c
detect
data
shown
overcom
obstacl
decid
spike
neuron
lysat
purifi
lamin
protein
incub
allow
cleavag
endogen
activ
subject
sampl
elisa
assay
detect
signific
increas
cleavag
lamin
protein
incub
perform
presenc
extract
deriv
camptothecinstress
neuron
wherea
increas
cleav
lamin
signal
observ
presenc
camptothecinstress
neuron
extract
fig
elisa
method
therefor
also
suitabl
detect
activ
sampl
contain
endogen
lamin
c
protein
detect
activ
absenc
endogen
lamin
cleavag
activ
local
nucleu
commonli
associ
cell
death
cleavag
nuclear
substrat
lamin
wherea
cytoplasm
local
activ
case
neurodegener
result
immedi
apoptosi
therefor
decid
test
whether
spike
cell
extract
pure
lamin
protein
detect
activ
earli
timepoint
transloc
nucleu
cleavag
endogen
lamin
end
transient
transfect
cell
fulllength
human
system
enzym
autoactiv
cytosol
transloc
nucleu
transfect
activ
form
becom
detect
western
blot
h
timepoint
fig
h
incub
low
level
endogen
lamin
cleavag
observ
elisa
method
indic
time
point
activ
present
nucleu
fig
howev
cell
lysat
supplement
purifi
lamin
protein
endogen
activ
allow
cleav
spike
protein
activ
could
alreadi
detect
h
increas
dramat
later
time
point
fig
agreement
western
blot
data
fig
indic
spike
method
detect
activ
endogen
lamin
cleav
thu
suitabl
detect
nonnuclear
activ
although
mesoscal
elisa
method
show
signific
advantag
commonli
use
veidbas
assay
system
measur
activ
still
requir
manual
cell
lysi
protein
quantif
step
easili
amen
highthroughput
screen
campaign
therefor
turn
highcont
imag
platform
allow
autom
liquid
handl
well
immunofluoresc
imag
quantif
use
primari
antibodi
specif
cleav
lamin
found
increas
perinuclear
stain
cell
induct
cell
death
camptothecin
fig
observ
bleb
nuclear
membran
consist
breakdown
nuclear
lamina
apoptosi
stain
cleav
lamin
protein
observ
nonstress
nonstress
camptothecinstress
cell
fig
use
nuclear
dapi
stain
refer
point
quantifi
perinuclear
immunofluoresc
ring
around
nucleu
fig
inset
found
increas
stain
intens
camptothecinstress
versu
nonstress
wt
mef
fig
background
signal
observ
mef
even
camptothecin
treatment
indic
detect
cleav
lamin
immunofluoresc
also
specif
fig
method
ideal
suit
highthroughput
intracellular
test
modul
activ
presenc
confound
proteolyt
activ
ie
studi
role
caspas
apoptosi
also
nonapoptot
development
signal
process
hamper
lack
specif
assay
measur
activ
singl
member
caspas
famili
neoepitop
antibodi
activ
form
caspas
avail
use
immunohistochem
western
blot
applic
howev
presenc
activ
caspas
fragment
necessarili
correl
proteolyt
activ
sinc
proteas
could
bound
either
endogen
exogen
inhibitor
especi
problemat
highthroughput
screen
campaign
aim
identifi
caspas
inhibitor
anoth
method
use
immunoprecipit
biotinyl
zvad
hand
specif
activ
caspas
quantit
reli
efficaci
immunoprecipit
western
blot
abl
accur
quantifi
activ
cell
cultur
therefor
develop
novel
activ
assay
base
cleavag
specif
substrat
protein
lamin
confirm
specif
lamin
cleavag
use
mef
stress
staurosporin
undergo
apoptosi
although
antibodi
use
studi
crossreact
cleav
lamin
c
specif
cleavag
maintain
sinc
protein
aris
gene
altern
splice
contain
cleavag
site
differ
ctermini
lamin
kda
longer
fig
cleav
fragment
detect
mef
develop
electrochemiluminescencebas
elisa
method
accur
quantifi
cleav
lamin
use
mesoscal
platform
new
method
improv
detect
limit
signalnois
ratio
commerci
avail
activ
assay
use
veid
peptid
substrat
furthermor
assay
specif
thu
superior
detect
activ
complex
sampl
varieti
differ
proteolyt
activ
cell
lysat
spike
purifi
lamin
protein
assay
appli
sampl
lack
endogen
lamin
c
embryon
primari
neuron
furthermor
method
amen
sampl
activ
lead
cleavag
endogen
nuclear
lamin
therefor
necessarili
associ
apoptosi
specif
due
use
protein
instead
peptid
substrat
even
though
veid
sequenc
deriv
cleavag
site
lamin
show
kcatkm
valu
lamin
higher
veid
indic
lamin
better
substrat
similar
effect
shown
proteas
involv
blood
figur
activ
quantifi
immunofluoresc
stain
cleav
lamin
mef
stress
camptothecin
stain
antibodi
cleav
lamin
analyz
autom
imag
platform
nuclei
counterstain
dapi
identifi
softwar
blue
circl
debri
red
circl
analyz
signal
intens
cleav
lamin
channel
quantifi
ring
around
nucleu
green
circl
b
quantit
perinuclear
stain
cleav
lamin
graph
untreat
mef
normal
fold
chang
stress
stress
nonstress
mef
compar
error
bar
sem
n
independ
experi
statist
signific
assess
anova
posthoc
bonferroni
comparison
coagul
substrat
bound
outsid
activ
site
proteas
exosit
specul
presenc
exosit
caspas
exist
proven
conclus
yet
exampl
exploit
protein
substrat
specif
develop
activ
assay
could
use
develop
specif
assay
member
caspas
famili
recent
emerg
import
player
neuron
dysfunct
degener
activ
link
sever
neurodegen
condit
ad
hd
stroke
direct
inhibit
enzym
well
target
player
activ
pathway
might
therefor
benefici
disord
show
cleavag
lamin
assess
highthroughput
set
use
highcont
imag
platform
make
ideal
intracellular
readout
test
intervent
decreas
activ
experi
carri
accord
protocol
anim
protocol
approv
ubc
committe
anim
care
canadian
council
anim
care
acveidafc
acdevdafc
acveidcho
zvadfmk
activ
enzym
purchas
enzo
bioscienc
lamin
antibodi
cell
signal
technolog
cleav
lamin
total
lamin
ac
western
blot
cat
no
cleav
lamin
mesoscal
elisa
cat
immunofluoresc
stain
cat
pure
lamin
protein
lamin
antibodi
abcam
cat
no
antibodi
fulllength
cell
signal
technolog
cat
antibodi
cell
signal
technolog
cat
antibodi
actin
chemicon
cat
camptothecin
staurosporin
sigma
cell
cultur
reagent
gibco
amount
enzym
indic
figur
nm
incub
mm
acveidafc
caspas
cleavag
buffer
mm
hepe
ph
mm
nacl
chap
mm
edta
glycerol
mm
dtt
h
black
plate
nunc
fluoresc
measur
everi
min
excit
nm
emiss
nm
initi
linear
part
curv
analyz
calcul
activ
site
concentr
acdevdafc
use
accord
protocol
differ
amount
zvadfmk
ad
reaction
ratio
reaction
veloc
inhibitor
vi
reaction
veloc
without
inhibitor
plot
inhibitor
concentr
concentr
determin
activ
site
concentr
caspas
specif
activ
caspas
enzym
use
determin
standard
curv
use
free
afc
acveidafc
acdevdafc
substrat
caspas
respect
result
specif
activ
nmol
acveidafcminmmol
nmol
acdevdafcminmmol
nmol
acdevdafcminmmol
assess
veid
cleavag
cell
lysat
lysat
correspond
mg
protein
mix
equal
volum
mm
acveidafc
caspas
cleavag
buffer
fluoresc
measur
describ
differ
concentr
acveidafc
substrat
mm
digest
nm
caspas
cleavag
buffer
h
black
plate
nunc
fluoresc
measur
everi
min
excit
nm
emiss
nm
initi
linear
part
curv
analyz
differ
concentr
lamin
protein
nm
digest
nm
caspas
cleavag
buffer
minut
reaction
stop
shockfreez
thaw
sampl
analys
mesoscal
elisa
system
cleavag
rate
calcul
lamin
concentr
plot
concentr
lamin
protein
calcul
km
kcat
fig
activ
assay
use
mesoscal
elisa
system
ng
pure
lamin
protein
subject
digest
differ
concentr
caspas
enzym
indic
figur
nm
caspas
cleavag
buffer
min
reaction
stop
shockfreez
thaw
sampl
analys
mesoscal
elisa
system
ml
reaction
correspond
ng
lamin
protein
spot
onto
mesoscal
elisa
plate
sampl
incub
room
temperatur
h
ml
bsa
pb
ad
per
well
plate
incub
h
room
temperatur
well
briefli
wash
time
ml
pb
contain
ml
antibodi
mix
ad
per
well
cleav
lamin
antibodi
cell
signal
goat
antimous
sulfotag
secondari
antibodi
msd
technolog
bsapb
h
incub
room
temperatur
well
briefli
wash
time
ml
pb
contain
ml
read
reagent
msd
technolog
ad
per
well
plate
read
mesoscal
platform
electrochemiluminesc
reader
msd
technolog
accord
manufactur
instruct
assay
use
mef
cell
lysat
lysat
dilut
pb
mgml
ml
spot
well
mesoscal
elisa
plate
plate
develop
describ
assay
use
neuron
transfect
cell
sampl
lysat
correspond
mg
total
protein
mix
ng
lamin
protein
caspas
cleavag
buffer
sampl
incub
h
ml
spot
well
mesoscal
elisa
plate
plate
develop
describ
mous
embryon
fibroblast
mef
mous
litterm
gener
day
embryo
result
timedpregn
heterozyg
breed
tissu
use
cultur
genotyp
gener
character
mice
describ
elsewher
singl
pup
dissect
ice
cold
pb
bodi
without
head
limb
liver
lung
heart
minc
centrifug
pellet
digest
trypsinedta
min
neutral
mef
medium
dulbecco
modifi
eagl
medium
high
glucos
fetal
calf
serum
mm
lglutamin
mm
nonessenti
amino
acid
mm
sodium
pyruv
mm
bmercaptoethanol
cell
passag
pipett
tip
centrifug
suspend
mef
medium
contain
dnase
centrifug
cell
suspend
fresh
medium
incub
min
room
temperatur
let
debri
cell
clump
settl
cell
supernat
seed
cell
cultur
flask
passag
cell
immort
transfect
larg
antigen
atcc
fugen
reagent
roch
accord
manufactur
instruct
immort
cell
select
propag
addit
mgml
medium
activ
cell
stress
nm
staurosporin
h
harvest
trypsin
cell
pellet
lyse
mm
tri
ph
mm
nacl
igep
mm
pefabloc
complet
proteas
inhibitor
cocktail
roch
ice
protein
concentr
determin
clear
lysat
centrifug
cortic
neuron
cultur
prepar
describ
previous
litterm
embryo
obtain
timedpregn
heterozyg
breed
tissu
use
cultur
genotyp
cultur
maintain
co
half
cultur
media
exchang
everi
day
day
vitro
mm
camptothecin
ad
media
induc
caspas
activ
cell
harvest
h
treatment
scrape
icecold
pb
supplement
proteas
inhibitor
mm
pefabloc
complet
proteas
inhibitor
cocktail
roch
cell
pellet
centrifug
store
lysi
cell
pellet
lyse
mm
hepe
ph
mm
nacl
igep
mm
edta
glycerol
mm
pefabloc
complet
proteas
inhibitor
cocktail
roch
ice
protein
concentr
determin
clear
lysat
centrifug
cultur
transfect
lysi
cell
cell
cultur
dulbecco
modifi
eagl
medium
supplement
fetal
calf
serum
mm
lglutamin
cell
transfect
human
cdna
ctermin
ddk
tag
use
fugen
reagent
roch
accord
manufactur
instruct
cell
harvest
h
transfect
trypsin
cell
pellet
lyse
mm
hepe
ph
mm
nacl
igep
mm
edta
glycerol
mm
pefabloc
complet
proteas
inhibitor
cocktail
roch
ice
protein
concentr
determin
clear
lysat
centrifug
cultur
lysi
cell
cell
cultur
dulbecco
modifi
eagl
medium
supplement
fetal
calf
serum
mm
lglutamin
cell
stress
um
camptothecin
differ
amount
time
harvest
trypsin
cell
pellet
lyse
mm
hepe
ph
mm
nacl
igep
mm
edta
glycerol
mm
pefabloc
complet
proteas
inhibitor
cocktail
roch
ice
protein
concentr
determin
clear
lysat
centrifug
western
blot
ng
pure
lamin
protein
subject
digest
differ
concentr
mm
caspas
cleavag
buffer
min
reaction
stop
shockfreez
thaw
sampl
run
bistri
gel
nupag
invitrogen
transfer
pvdf
membran
electroblot
membran
develop
primari
antibodi
bsapb
fluoresc
label
secondari
antibodi
licor
odyssey
infrar
imag
system
use
detect
western
blot
cell
lysat
mg
total
protein
run
bistri
gel
nupag
invitrogen
process
describ
mef
seed
cell
per
well
plate
n
treatment
follow
day
cell
treat
camptothecin
mm
final
hour
post
stress
cell
wash
pb
fix
formaldehyd
em
pb
minut
wash
pb
permeabil
tritonx
primari
antibodi
mous
cleav
lamin
cell
signal
technolog
ad
normal
goat
serum
incub
overnight
plate
wash
twice
pb
ad
secondari
antibodi
alexafluor
antimous
igg
invitrogen
normal
goat
serum
dna
stain
dye
hoechst
invitrogen
minut
room
temperatur
plate
wash
twice
left
pb
label
cell
analys
use
thermofish
cellom
arrayscan
vti
high
content
scan
vhc
microscop
use
version
softwar
arrayscan
vti
captur
imag
use
orcaer
camera
two
channel
applic
assay
filter
nm
use
autom
imag
analysi
quantifi
nuclei
number
cleav
lamin
respect
cellom
toolbox
compartment
analysi
use
algorithm
encircl
perinuclear
stain
cleav
lamin
primari
object
hoechst
channel
identifi
nucleu
cell
total
count
per
well
channel
perinucleu
identifi
circ
pixel
outsid
primari
object
algorithm
measur
pixel
intens
background
stain
meanavgcirintens
channel
use
analysi
vhc
analysi
tool
export
microsoft
excel
spreadsheet
graphpad
prism
analysi
figur
activ
site
titrat
caspas
exact
activ
site
concentr
caspas
use
determin
titrat
enzym
pancaspas
inhibitor
zvadfmk
tif
figur
km
determin
lamin
indic
concentr
lamin
protein
digest
nm
sampl
analys
mesoscal
elisa
system
b
cleavag
rate
determin
slope
curv
plot
lamin
concentr
obtain
valu
km
kcat
curv
fit
use
builtin
function
graphpad
prism
softwar
packag
tif
